Full-Time

Trade Account Specialist

Posted on 3/12/2025

Pfizer

Pfizer

10,001+ employees

Develops and manufactures biopharmaceuticals and vaccines

Compensation Overview

$21.82 - $36.36/hr

+ Overtime + Weekend Pay + Holiday Pay + Other Pay Premiums

Mid, Senior

No H1B Sponsorship

Memphis, TN, USA

Work Location Assignment: Hybrid; Relocation assistance may be available based on business needs and/or eligibility.

Category
Sales & Account Management
Required Skills
Customer Service
Excel/Numbers/Sheets
Requirements
  • High School diploma with 4+ years of customer service / account management experience.
  • Excellent analytical skills
  • Excellent verbal and written communication skills
  • Ability to handle multiple tasks and deadlines in a timely and organized manner
  • Strong interpersonal skills in a multi-team environment
  • Proficiency in Microsoft Office & Excel
Responsibilities
  • Collaboratively engage customers on order analysis, forecast adjustments, inventory level analysis, and cycle time updates.
  • Utilize Pfizer’s data warehouse and Business Objects application to review customer orders, analyze operational trends, and research customer reported issues.
  • Proactively interact with Supply Planning on high impact orders, the warehouse on OS&D shipping exceptions, as well as other internal stakeholders including Deployment, Transportation and Account Directors, to quickly resolve potential customer facing issues.
  • Closely work with assigned buyers to identify and communicate relevant market-related data and competitive intelligence to Pfizer’s Supply Planning and Customer Operations teams.
  • Work collaboratively with customers, Pfizer’s Deduction Specialist and Credit departments to resolve claims / deductions, which may include contract fines, shipping discrepancies, pricing, and returns, to name a few.
  • Maintain a detailed working knowledge of Pfizer’s trade policies, SOP’s and standard business processes, and consistently apply that knowledge to daily operational tasks.
  • Positively represent Pfizer by providing exceptional customer service to a wide range of external customers including consumers, pharmaceutical buyers, and medical professionals.
  • Manage both internal and 800 calls as well as email correspondence accurately, and in a professional and punctual manner.
  • Provide operational assistance to customers and internal clients that support the attainment of business objectives.
  • Assist both customers and Pfizer colleagues with escalated inquiries or problems, increasing the ability to provide our customers with prompt resolution.
  • Support special projects as assigned including claims initiatives, collection efforts, and miscellaneous internal and external requests.
  • Successfully operate in a collaborative team environment, ensuring individual/team metrics, & working to improve quality while maintaining respect for people.
  • Collaborate with management team to examine practices and procedures as part of a continuous business improvement effort.
Desired Qualifications
  • Experience in SAP ERP, Sales Order Management
  • Experience working in pharmaceutical industry
  • Excel super user

Pfizer is a biopharmaceutical company that focuses on creating and producing healthcare products, including medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold to various clients such as governments, healthcare providers, and patients around the world. Pfizer's products include vaccines, oncology treatments, and other specialized medicines. A notable achievement is its partnership with BioNTech to develop a vaccine for COVID-19, which has played a significant role in addressing the pandemic. Pfizer aims to improve public health by ensuring access to vaccines, especially for underserved populations, and continues to grow its product offerings with new approvals and treatments.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • Activist investor Starboard Value's $1B stake may drive strategic changes and increase value.
  • Pfizer's investment in Enara Bio strengthens its position in the immunotherapy market.
  • Backing Promise Bio aligns with Pfizer's strategy to enhance its precision medicine portfolio.

What critics are saying

  • Emerging biotech companies like Trimtech and Normunity could impact Pfizer's market share.
  • Slowdown in COVID-19 vaccine demand poses potential revenue challenges for Pfizer.
  • Activist investor involvement may pressure Pfizer to alter business strategies.

What makes Pfizer unique

  • Pfizer's partnership with BioNTech led to a highly effective COVID-19 vaccine.
  • Pfizer invests in AI disease models, enhancing R&D capabilities and drug discovery.
  • Pfizer's focus on precision medicine diversifies its therapeutic areas and strengthens its portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance

Company News

Finsmes
Mar 5th, 2025
Trimtech Therapeutics Raises $31M in Seed Funding

Trimtech Therapeutics, a Cambridge, UK-based biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, raised $31M in Seed funding

Business Wire
Jan 16th, 2025
Normunity Closes $75 Million Series B Financing to Advance Lead Drug Program Into the Clinic and Broaden Pipeline of Novel Anti-Cancer Therapies Targeting Untapped Drug Mechanisms

Normunity, a biotechnology company creating novel anti-cancer therapies, today announced that it has closed a Series B financing for $75 million. The

TechCrunch
Oct 23rd, 2024
Promise Bio exits stealth backed by Pfizer and AstraZeneca | TechCrunch

The company has made it easier to test for different protein modifications which are critical to the treatment of autoimmune diseases.

The Wall Street Journal
Oct 7th, 2024
Exclusive | Activist Starboard Value Takes $1 Billion Stake in Pfizer

The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments had slowed.

Benzinga
Oct 3rd, 2024
Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens®

New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapital and SV Health InvestorsEnara Bio's EDAPT® platform is

INACTIVE